GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Trinity Biotech PLC (FRA:TRB) » Definitions » Cyclically Adjusted Book per Share

Trinity Biotech (FRA:TRB) Cyclically Adjusted Book per Share : €17.14 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Trinity Biotech Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Trinity Biotech's adjusted book value per share for the three months ended in Dec. 2023 was €-2.865. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €17.14 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Trinity Biotech's average Cyclically Adjusted Book Growth Rate was -16.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -10.80% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -9.00% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -8.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Trinity Biotech was 12.30% per year. The lowest was -21.40% per year. And the median was -6.35% per year.

As of today (2024-05-15), Trinity Biotech's current stock price is €2.12. Trinity Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was €17.14. Trinity Biotech's Cyclically Adjusted PB Ratio of today is 0.12.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Trinity Biotech was 2.27. The lowest was 0.08. And the median was 0.67.


Trinity Biotech Cyclically Adjusted Book per Share Historical Data

The historical data trend for Trinity Biotech's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trinity Biotech Cyclically Adjusted Book per Share Chart

Trinity Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.50 22.29 22.64 21.67 17.14

Trinity Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.67 19.92 19.83 19.55 17.14

Competitive Comparison of Trinity Biotech's Cyclically Adjusted Book per Share

For the Diagnostics & Research subindustry, Trinity Biotech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trinity Biotech's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Trinity Biotech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Trinity Biotech's Cyclically Adjusted PB Ratio falls into.



Trinity Biotech Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Trinity Biotech's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book= Book Value per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-2.865/120.1096*120.1096
=-2.865

Current CPI (Dec. 2023) = 120.1096.

Trinity Biotech Quarterly Data

Book Value per Share CPI Adj_Book
201403 29.613 100.573 35.365
201406 31.276 100.773 37.278
201409 32.054 100.474 38.318
201412 33.877 99.576 40.863
201503 39.433 99.975 47.375
201506 38.747 100.573 46.274
201509 39.232 100.274 46.993
201512 40.975 99.676 49.375
201603 39.816 99.676 47.978
201606 39.126 101.072 46.496
201609 40.569 100.274 48.594
201612 22.306 99.676 26.879
201703 22.111 100.374 26.459
201706 20.583 100.673 24.557
201709 21.325 100.474 25.493
201712 13.162 100.075 15.797
201803 12.745 100.573 15.221
201806 13.639 101.072 16.208
201809 13.958 101.371 16.538
201812 9.263 100.773 11.040
201903 9.351 101.670 11.047
201906 8.272 102.168 9.725
201909 8.456 102.268 9.931
201912 1.015 102.068 1.194
202003 0.166 102.367 0.195
202006 -0.151 101.769 -0.178
202009 1.436 101.072 1.706
202012 -0.436 101.072 -0.518
202103 -0.026 102.367 -0.031
202106 -0.099 103.364 -0.115
202109 0.165 104.859 0.189
202112 -0.067 106.653 -0.075
202203 -1.060 109.245 -1.165
202206 1.964 112.734 2.093
202209 0.879 113.431 0.931
202212 -0.270 115.425 -0.281
202303 -0.809 117.618 -0.826
202306 -1.375 119.611 -1.381
202309 -2.137 120.708 -2.126
202312 -2.865 120.110 -2.865

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Trinity Biotech  (FRA:TRB) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Trinity Biotech's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=2.12/17.14
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Trinity Biotech was 2.27. The lowest was 0.08. And the median was 0.67.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Trinity Biotech Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Trinity Biotech's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Trinity Biotech (FRA:TRB) Business Description

Traded in Other Exchanges
Address
IDA Business Park, Bray, County Wicklow, Dublin, IRL, A98 H5C8
Trinity Biotech PLC is in the business of development, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita, and others. Geographically, it has two segments namely the Americas, and Rest of World - Ireland of which it derives a majority of its revenues from the Americas segment.

Trinity Biotech (FRA:TRB) Headlines

No Headlines